NuGen Medical Devices Inc. (TSXV:NGMD)

NuGen Medical Devices Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	0.26	1.01	0.33	0.15	0.14
Revenue Growth (YoY)	-74.46%	204.73%	117.52%	10.69%	191.04%
Cost of Revenue	0.13	0.49	0.17	0.05	0.05
Gross Profit	0.13	0.52	0.16	0.1	0.09
Selling, General & Admin	4.35	5.68	8.21	4.89	6.05
Other Operating Expenses	4.81	-	-	-	1.72
Total Operating Expenses	9.16	5.68	8.21	4.89	7.76
Operating Income	-9.03	-5.16	-8.05	-4.79	-7.67
Total Non-Operating Income (Expense)	1.26	-0.06	-1.28	-0.78	0.57
Pretax Income	-7.77	-5.22	-9.33	-5.57	-7.1
Provision for Income Taxes	0.05	0.01	0.03	0	0
Net Income	-7.83	-5.23	-9.36	-5.58	-7.11
Net Income to Common	-7.83	-5.23	-9.36	-5.58	-7.11
Shares Outstanding (Basic)	224	214	168	90	69
Shares Outstanding (Diluted)	224	214	168	90	69
Shares Change (YoY)	4.41%	27.89%	86.08%	31.20%	26.95%
EPS (Basic)	-0.03	-0.02	-0.05	-0.06	-0.10
EPS (Diluted)	-0.03	-0.02	-0.05	-0.06	-0.10
Shares Outstanding	227.04	214.42	167.67	96.56	86.02
Free Cash Flow	-3.87	-4.72	-6.72	-2.13	-4.1
Free Cash Flow Per Share	-0.02	-0.02	-0.04	-0.02	-0.06
Gross Margin	51.31%	51.68%	49.74%	65.09%	67.00%
Operating Margin	-3501.40%	-510.70%	-2428.48%	-3146.56%	-5573.13%
Profit Margin	-3034.00%	-517.47%	-2825.02%	-3661.07%	-5163.23%
FCF Margin	-1499.59%	-467.79%	-2026.89%	-1399.36%	-2977.84%
EBITDA	-8.34	-4.51	-7.36	-4.14	-6.88
EBITDA Margin	-3233.49%	-446.76%	-2220.02%	-2718.36%	-4998.80%
EBIT	-9.03	-5.16	-8.05	-4.79	-7.67
EBIT Margin	-3501.40%	-510.70%	-2428.48%	-3146.56%	-5573.13%
Effective Tax Rate	-0.67%	-0.13%	-0.36%	-0.06%	-0.04%

Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.